Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Irma Csanalosi"'
Publikováno v:
Pharmacopsychiatry. 24:127-131
In summary, the clinical results of this double-blind study clearly show that imipramine, as expected, demonstrated significant antidepressive properties in outpatients suffering from major depressive disorders. In contrast, adinazolam showed rather
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb8d5be80677f5eb5af8880bfc3855e7
https://doi.org/10.1055/s-2007-1014455
https://doi.org/10.1055/s-2007-1014455
Autor:
Hack R. Chung, Howard Rosenfeld, Karl Rickels, Harold S. Feldman, Edward M. Whalen, Irma Csanalosi, Charles C. Weise
Publikováno v:
Psychopharmacologia. 34:361-376
Clomipramine (75–125 mg/day), a relatively new tricyclic anti-depressant, was compared to amitriptyline (75–125 mg/day) in a double-blind 6 week trial carried out with 93 psychiatric and 75 non-psychiatric depressed out patients. Psychiatric pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e639628f67690e280cce43e96ffb7d41
https://doi.org/10.1007/bf00422559
https://doi.org/10.1007/bf00422559
Autor:
Nathanson Je, Karl Rickels, Jorge A. Pereira-Ogan, Warren G. Case, Parish Lc, Irma Csanalosi, Mirman Mj
Publikováno v:
American Journal of Psychiatry. 131:592-595
The efficacy of chlormezanone, an infrequently prescribed minor tranquilizer, was tested in a six-week double-blind trial involving 154 anxious outpatients. The results showed that chlormezanone (800 mg./day) was significantly more effective than pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::588de45f5a07330e41b205d468e09466
https://doi.org/10.1176/ajp.131.5.592
https://doi.org/10.1176/ajp.131.5.592
Autor:
Irma Csanalosi, Arthur Schless, Richard J. Morris, Howard Rosenfeld, Jorge A. Pereira-Ogan, Lester Sablosky, Joshua Werblowsky, Karl Rickels
Publikováno v:
Psychopharmacology. 52:129-136
Halazepam (160 mg/day) was compared to diazepam (20 mg/day) and to a placebo in a double-blind study with anxious neurotic outpatients from general family practice and a symptomatic volunteer clinic. One hundred twenty-five patients completed at leas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::601cba95d9c1db9e3e113578772962f1
https://doi.org/10.1007/bf00439099
https://doi.org/10.1007/bf00439099
Autor:
Irma Csanalosi, Karl Rickels, William Stepansky, Charles C. Weise, Edward M. Whalen, B. Wheeler Jenkins
Publikováno v:
The Journal of Clinical Pharmacology and New Drugs. 11:440-449
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::684d0c1b51d49802d6b8fc8cf4cd25e6
https://doi.org/10.1177/009127007101100608
https://doi.org/10.1177/009127007101100608
Autor:
Irma Csanalosi, Harris A. Ross, Paul Greisman, Joshua Werblowsky, Karl Rickels, Harvey Harris, David Cohen
Publikováno v:
The American journal of psychiatry. 140(1)
The authors report the results of a large-scale double-blind study comparing the anxiolytic effects of alprazolam, a triazolobenzodiazepine; diazepam, a 1,4-benzodiazepine; and placebo in 151 anxious outpatients. Alprazolam and diazepam produced simi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0557eee10ac6ebbf87313e7815f06b37
https://pubmed.ncbi.nlm.nih.gov/6128927
https://pubmed.ncbi.nlm.nih.gov/6128927
Publikováno v:
Archives of general psychiatry. 37(5)
• Two dosage schedules of amitriptyline hydrochloride, once daily vs three times daily, were compared in a group of 124 nonpsychotic depressed outpatients. After four weeks of treatment, patients on the once daily schedule had improved significantl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4e728eb0d4ec2405b5a7f3c7e4be451
https://pubmed.ncbi.nlm.nih.gov/7377911
https://pubmed.ncbi.nlm.nih.gov/7377911
Autor:
Arthur Schless, Irma Csanalosi, W. George Case, Karl Rickels, Charles C. Weise, Joshua Werblowsky
Publikováno v:
The American journal of psychiatry. 138(1)
In a double-blind, controlled study 158 outpatients with unipolar depression were treated for six weeks with amoxapine, imipramine, or placebo to assess the antidepressant effects of the new dibenzooxazepine compound, amoxapine. Forty-five amoxapine,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::136c9e31c3e50c5a7ac73a529471aec9
https://pubmed.ncbi.nlm.nih.gov/7446776
https://pubmed.ncbi.nlm.nih.gov/7446776
Publikováno v:
Journal of clinical psychopharmacology. 8(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74502c9fd56fb78c4dd19fcdfd839756
https://pubmed.ncbi.nlm.nih.gov/2895127
https://pubmed.ncbi.nlm.nih.gov/2895127
Autor:
W. George Case, Hack R. Chung, Jorge A. Pereira-Ogan, Robert W. Downing, Karl Rickels, Irma Csanalosi
Publikováno v:
The American journal of psychiatry. 131(1)
In a four-week study of 08 volunteer subjects with mixed symptoms of anxiety and depression, amitriptyline produced significantly more improvement than placebo. Significant differences were noted between the amitriptyline and placebo treatment groups
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::212973dd221a07f3f5d37527e937dec6
https://pubmed.ncbi.nlm.nih.gov/4585770
https://pubmed.ncbi.nlm.nih.gov/4585770